Patent ID: 11884645
Assignee: INFLAZOME LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 4:
5. The compound or the pharmaceutically acceptable salt or solvate thereof as claimed in claim 1, wherein R1 is further substituted with one or two substituents independently selected from
halo; —Rβ; —OH; —ORβ; —Rα-halo; —Rα—Rβ; —Rα—OH; —Rα—ORβ; —CHO; —CORβ; —COORβ; —OCORβ; —Rα—CHO; —Rα—CORβ; —Rα—COORβ; —Rα—OCORβ; —O—Rα—OH; or —O—Rα—ORβ;
wherein each —Rα— is independently selected from an alkylene, alkenylene or alkynylene group, wherein the alkylene, alkenylene or alkynylene group contains from 1 to 6 atoms in its backbone, wherein one or more carbon atoms in the backbone of the alkylene, alkenylene or alkynylene group may optionally be replaced by one or two heteroatoms N or O, and wherein the alkylene, alkenylene or alkynylene group may optionally be substituted with one or more halo and/or —Rβ groups; and
wherein each —Rβ is independently selected from a C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl group, and wherein any —Rβ may optionally be substituted with one or more halo, —OH, —NH2, —CN, —NO2, —N3, —SH, —SO2H, —SO2NH2, or oxo (═O).